|
Schedule |
Activity/Talk Title |
Guest Speaker |
|
|---|---|---|---|
|
December, 2nd, 2020 |
|||
|
9:00 – 9:30h |
Opening Remarks |
||
|
Head of the School of Medicine/UFC |
Dr. João Macedo, MD, PhD |
||
|
Research Provost/UFC |
Dr. Jorge Herbert Lira, PhD | ||
|
Coordinator of the UFC CAPES Print in Translational Neurosciences |
Dr. Reinaldo Oriá, PhD |
||
|
Chairperson |
Dr. Fábio Miyajima |
||
|
09:30–10:20h |
Opening Lecture |
||
|
Novel genetic variants underpinning CNS function and disease risk |
Dr. John Quinn, University of Liverpool |
||
|
10:20h-10:30h |
Coffee Break |
||
|
First session: Stroke and neurovascular diseases |
|||
|
Chairperson |
Dr. Reinaldo B. Oriá |
||
|
10:30–12:10h |
Microglia and macrophage responses after brain injury: functional diversities and opportunities |
Dr. Jun Chen, MD, Pittsburgh Institute of Brain Disorders & Recovery, University of Pittesburg, PA, USA |
|
|
Docosanoids and elovanoids from omega-3 fatty acids are a novel class of homeostatic lipid mediators that protect brain after experimental stroke |
Dr. Ludmila Belayev, MD, Neuroscience Center of Excellence, Louisiana State University, Health Sciences Center, USA. |
||
|
12:20-14:00h |
Lunch Break |
||
|
14:00-14:50h |
Viral infection disrupts juvenile cerebrovasculature |
Dr. Andre Obenaus, PhD, Preclinical and Translational Imaging Center, University of California, Irvine, USA |
|
|
Second session: Neuroinflammation and neurogenesis |
|||
|
Chairperson |
Dr. Reinaldo B. Oriá |
||
|
14:55h-17:30h |
Neurotoxins, E(motion)s, and Circulating Extracellular Vesicles |
Dr. Frederico C. Pereira, PhD, Universidade de Coimbra, Portugal |
|
|
Methyl mercury neurotoxicity and impact on brain neurogenesis |
Dr. João Oliveira Malva, PhD, Universidade de Coimbra, Portugal |
||
|
mTOR and Neuroinflammation |
Dr. Filipe Palavra, MD, Universidade de Coimbra, Portugal |
||
|
Coffee Break |
|||
|
December, 3rd, 2020 |
|||
|
Third session: Neuropsychiatric disorders and interventions |
|||
|
Chairperson |
Dr. Danielle M. Gaspar |
||
|
09:25–10:15h |
Well-Being and Resilience Mind-Body Interventions |
Dr. Danilo Garcia, PhD, University of Gothenburg, Sweden |
|
|
10:15-10:30h |
Coffee Break |
||
|
Chairperson |
Dr. Danielle M. Gaspar |
||
|
10:30–12:00h |
Mitochondrial dysfunction in bipolar disorder |
Dr. João Quevedo, University of Texas, USA |
|
|
Development of a novel therapeutic strategy to prevent the loss of BDNF signalling in Alzheimer’s disease |
Dr. Maria José Diógenes, PhD, Instituto de Medicina Molecular, Universidade de Lisboa, Portugal |
||
|
12:00:12:50h |
Lunch Break |
||
|
Fourth Session: Sleep and Sleep disorders |
|||
|
Chairperson |
Dr. Pedro Carvalhedo Bruin |
||
|
14:00-15:30h |
Sleep: A marker and potential treatment for Alzheimer's disease |
Dr. Brendan Lucey, MD, Washington University, Saint Louis, USA |
|
|
Sleep and movement disorders |
Dr. Veralice Sales de Bruin, Federal University of Ceara |
||
|
16:00-20:00h |
Poster Sessions |
Selected Referees |
|
|
Dr. Silvânia Vasconcelos |
|||
|
Dr. Clea Florenço Sousa |
|||
|
Dr. Raquel Montenegro |
|||
|
December, 4th, 2020 |
|||
|
Fifth Session: Neurodevelopmental and neurodegenerative disorders |
|||
|
Chairperson |
Dr. Geanne M. Andrade |
||
|
08:30–12:40h |
Mercury: What can we learn from the Amazon |
Dr. Maria Elena Crespo-Lopez, Federal University of Para |
|
|
Clusterin mitigates dispersion of alpha-synuclein and ER stress in a cell model of Parkinson’s disease |
Dr. Merari Ferrari, University of São Paulo |
||
|
Revisiting FDA-approved antagonists of A2A receptors to manage Parkinson's disease |
Dr. Rodrigo Cunha, Universidade de Coimbra, Portugal |
||
|
Neurodevelopmental and Executive Function Outcomes in Children Born Prematurely |
Dr. Sarah Miller , University of Virgina, USA |
||
|
12:40-13:00h |
Closing Remarks |
Dr. Reinaldo Oriá and Organizing Committee |
|
© Copyright 2020 | SINE 2020
